Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 20/20 | 0.74 |
| ▸ | ADRB1 | P08588 | 11/20 | 0.74 |
| ▸ | ADRB2 | P07550 | 12/20 | 0.73 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.63 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.63 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.63 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.63 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.63 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7117049 | 0.99 | ADRB3 (0.73) | ADRB3ADRB1ADRB2ADRA2AADRA2B | |
| SCHEMBL6799878 | 0.93 | ADRB3 (0.72) | ADRB3ADRB1ADRB2ADRA2AADRA2B | |
| SCHEMBL6796033 | 0.90 | ADRB3 (0.72) | ADRB3ADRB1ADRB2 | |
| SCHEMBL6796023 | 0.90 | ADRB3 (0.72) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7134549 | 0.89 | ADRB3 (0.67) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7134542 | 0.89 | ADRB3 (0.67) | ADRB3ADRB1ADRB2 | |
| SCHEMBL6806557 | 0.89 | ADRB3 (0.75) | ADRB3ADRB1ADRB2ADRA2AADRA2B | |
| SCHEMBL6802649 | 0.88 | ADRB3 (0.74) | ADRB3ADRB1ADRB2ADRA2AADRA2B | |
| SCHEMBL6802642 | 0.88 | ADRB3 (0.74) | ADRB3ADRB1ADRB2ADRA2AADRA2B | |
| SCHEMBL6801088 | 0.87 | ADRB3 (0.77) | ADRB3ADRB1ADRB2ADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002006274-A1 | N-(4-SULFONYLARYL)CYCLYLAMINE-2-HYDROXYETHYLAMINES AS BETA-3 ADRENERGIC RECEPTOR AGONISTS | WYETH (US) | 2002-01-24 | — | — | WO | claimed |
| WO-2002006274-A1 | N-(4-SULFONYLARYL)CYCLYLAMINE-2-HYDROXYETHYLAMINES AS BETA-3 ADRENERGIC RECEPTOR AGONISTS | WYETH (US) | 2002-01-24 | — | — | WO | disclosed |